Zhongshan University China large biomedical application technology research institute Dr. Dean of students

 

By Dr. Ren Sheng presided over the "oil of zedoary turmeric hepatic artery embolization in the treatment of primary liver cancer" project, won the two prize in 1997 national TCM Bureau of technical achievements. Treatment of "traditional Chinese medicine" cancer Ling 1 "in theprimary lung cancer" project won the two prize of scientific and technological achievements in Heilongjiang Province, "cancer Ling 1" is arsenic extract. Later, academician Sun Yan,academician Chen Zhu regarding this drug research foundation mechanism. The drug is currently named arsenious acid preparation, treatment with Arsenious Acid domestic hospital clinical expert artery intervention, still referring doctor in 1994 to develop a scheme (the schemeincluded Heilongjiang Medical Journal).

In 20 years of work, completed a number of high difficulty operation, such as: super selectivehepatic artery embolization of Rhizoma Bletillae, second thoracic vertebral angioplasty,percutaneous transabdominal anterior lumbar discectomy, percutaneous radiofrequency ablation of hepatic portal metastatic abdominal tumor, cervical disc anterior interventionalremoved operation, huge retroperitoneal tumor interventional therapy, carotid bifurcation stentplacement via jugular vein, portal vein and vena cava shunt, giant hemangioma support the operation of isolation, lower extremity arterial occlusive disease in minimally invasive opensurgery and so on, the treatment of all kinds of patients more than 1 cases. The first in China to carry out the disc minimally invasive interventional treatment of infertility, minimally invasiveinterventional therapy, traditional Chinese medicine as embolic agent tumor minimally invasiveinterventional therapy, femoral head necrosis of double interventional therapy and other projects. Involved in diseases and technology and its wide, of various minimally invasive techniques to master the skill.

In 2003 as a student of Dr. began to focus on the application of dry cell. At that time, stem celltherapy is limited to simple treatment technology of autologous cell culture and intravenous drip,disease choice rarely, had a vague idea that as long as the cells enter the body, that is, walk tothe place of the disease. In this concept under the influence, the application of stem celltechnique is very simple, the treatment effect is very poor. As a keen feeling of stem cell inputway doctor is an important factor to influence the treatment effect. In 2009 Dr Xiang Pengcooperation, using stem cells into hepatic artery interventional technology site treated 1 cases of liver cirrhosis patients in Indonesia, the patient before the treatment of severe ascites,elevated transaminases, severe jaundice liver function grade 3. 1 weeks after the treatment of ascites disappeared, increase in albumin, liver function. This case was completed in June 27, 2009, is the first domestic cases of allogeneic stem cell intervention for successful treatment ofcirrhosis cases through, this is a milepost type treatment case, this patient to doctor team great confidence. During the next 2009 - 2013, doctor using his excellent minimally invasive techniquecombined with stem cell technology, the treatment of various diseases in the success of thenearly one thousand cases of patients. Include: severe liver disease, uremia, thyroid function,low complications of diabetes, Parkinson's disease, the sequelae of cerebral vascular disease,ischemic necrosis of femoral head, bone and joint injury, spinal sclerosis, psoriasis, myocardial infarction sequela, gout pain, rheumatoid arthritis, scleroderma, systemic lupus erythematosus,thrombocytopenic purpura, chronic obstructive pulmonary disease emphysema, chronic pancreatitis. Also in the plastic and cosmetic technology is developed, the successful completion of the scaffold cell breast augmentation, scaffold facial skin filling operation, micro needleimplantation cytokine skin improvement technology, micro needle implanted hair surgery and so on, and built a number of the first: the first cases of allogeneic interventional treatment of transplant renal failure. The first cases of avascular necrosis of the femoral head to geneintervention, the first case of allogeneic COPD interventional therapy and so on. As a doctoral student at present 7 technologies are available to complete the application of stem cell therapy,including coronary intervention and intravenous infusion and percutaneous viscera punctureinjection, medullary cavity injection, muscle injection, the dermis layer micro needle injection,acupuncture point injection technology, is currently the use of mesenchymal stem cells for treatment of clinical disease types of most people, and cross professional treatment of most people, the first domestic. Especially the original characteristics of the combination of traditional Chinese and Western Medicine (stem cell therapy of point injection) and for trauma repair andplastic surgery (scaffold technology), these two technologies have been applied for the national invention patent. The other in the treatment process of stem cells, application program, and constantly improve the stem cells such as dosage, course of treatment. In this regard,accumulated a lot of experience, for the wide application of stem cell policy after the opening of the. Done a lot and adequate preparation.

As a student of Dr. also invented the small molecule cell modification technology, can bemodified to become immune cells stem cell activation factor, achieve the autologous internal organs stem cell regeneration by immunizing cells treatment, make up the current application of stem cell policy restrictions. Immune cell is the cell regulations permit application. This technology in the special stage at present, should have broad market.

Huada biomedical application technology research institute dedicated to research and clinicaltransformed cell basis, established the Biological Island five star hospital, team for the University of Chicago, New York State University, University of Hong Kong, Zhongshan University and otherChinese scientists. Gold you heal to plug in implementation of diseases related to stem cell research immune regeneration cell technology,